TickerWorth Open the interactive view →

SBI Life Insurance Company Limited (SBILIFE.NS) — Valuation Snapshot

Updated Sep 3, 2026 · bank / insurer · relative-multiples view · descriptive, not a DCF, not advice

This is a bank / insurer / financial. A free-cash-flow DCF is structurally the wrong lens here (their debt and float are raw material, not financing), so we value it on relative multiples — price-to-book and price-to-earnings — instead.
Price
₹1,719
Market cap
₹1,724,456,894,464
52-week high
₹2,132
52-week low
₹1,700
Currency
INR
Exchange
NSE

SBI Life Insurance Company Limited (SBILIFE.NS) is a bank, insurer or other financial, and a free-cash-flow discounted-cash-flow (DCF) model is structurally the wrong lens for it: for these businesses debt and float are raw material, not financing, so there is no meaningful 'free cash flow' to discount. Instead of a misleading intrinsic-value number, this page reads SBILIFE.NS the way financials are actually valued — on relative multiples such as price-to-earnings and, above all, price-to-book — plus a plain description of where the stock trades. It is a descriptive snapshot, not a valuation, and not investment advice.

On the numbers we do have, SBILIFE.NS trades at a recent price of ₹1,719, a market capitalisation of about ₹1,724,456,894,464, sitting 4% of the way up its 52-week range (₹1,700–₹2,132), on the NSE.

The standard alternative to a DCF is relative valuation — comparing SBILIFE.NS's trading multiples against a sector benchmark. Here that gives P/E of 67.1× (richer than the peer median of 15.5×); Fwd P/E of 49.2× (richer than the peer median of 14.2×); P/B of 8.6× (richer than the peer median of 2.8×); P/S of 1.4× (cheaper than the peer median of 5.1×); EV/EBITDA of 58.0× (richer than the peer median of 23.3×); Dividend yield of 0.2% (richer than the peer median of 1.7%). A cheaper multiple than peers can flag a discount or a market that expects weaker growth; it is a comparison, not a recommendation.

The asset, or book-value, lens is the classic tool for asset-heavy businesses and financials. SBILIFE.NS shows a price-to-book (P/B) of 8.56 and book value of ₹200.67 per share. Price-to-book compares the market price to the accounting net-asset value per share; below 1.0 can mean a discount to net assets or that the market is pricing in trouble — descriptive either way, never a buy signal on its own.

Finally, a price-based read — explicitly not a valuation. SBILIFE.NS is in a down-trend (price below both its 50- and 200-day averages), trading -19.4% from its 52-week high. Over the past year the stock is -4.0%. Moving-average trend and 52-week position describe where the stock has traded; they say nothing about what it is worth.

To be exact about what this page is not: we are not saying the numbers for SBILIFE.NS are unavailable. They are, and they are above. We are saying a discounted-cash-flow model is the wrong instrument for this kind of business, and publishing one anyway — because the inputs happen to exist — would be a precise answer to the wrong question. Refusing is the more useful answer, and it is the same rule we apply to every name in this category.

Relative valuation — SBILIFE.NS vs peers

MultipleSBILIFE.NSPeer median
P/E67.1×15.5×richer than
Fwd P/E49.2×14.2×richer than
P/B8.6×2.8×richer than
P/S1.4×5.1×cheaper than
EV/EBITDA58.0×23.3×richer than
Dividend yield0.2%1.7%richer than

Sector benchmark (bellwethers, not direct competitors).

Asset / book-value view

Price / book (P/B)
8.56
Book value / share
₹200.67

Price-to-book compares the market price to the accounting net-asset value per share. Most useful for asset-heavy businesses, banks and insurers.

Price-based snapshot

50-day avg
₹1,815
200-day avg
₹1,905
From 52-wk high
-19.4%
1-year momentum
-4.0%

Price-based, not a valuation. Moving-average trend and 52-week position describe where the stock has traded — they say nothing about fair value.

Explore more

Most undervalued stocks (per our valuation) · All valued stocks · Interactive SBILIFE.NS view

A descriptive, available-data snapshot and relative comparison — NOT a DCF, NOT a price target, and NOT investment advice. TickerWorth is an educational tool, not a licensed investment adviser. Figures are estimates derived from public market data and can be wrong, stale or incomplete.